# Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants

> **NCT00859547** · PHASE4 · COMPLETED · sponsor: **ZymoGenetics** · enrollment: 30 (actual)

## Conditions studied

- Blood Loss, Surgical

## Interventions

- **BIOLOGICAL:** rThrombin, 1000 IU/mL

## Key facts

- **NCT ID:** NCT00859547
- **Lead sponsor:** ZymoGenetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859547, "Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00859547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*